S&P 500 · SPY
739.64
▲ +6.64 (+0.91%)
DOW JONES · DIA
514.68
▲ +0.41 (+0.08%)
NASDAQ · QQQ
659.54
▲ +12.49 (+1.93%)
GOLD · GLD
$371.05
▼ -4.44 (-1.18%)
OIL (WTI) · USO
$147.70
▼ -0.51 (-0.34%)
BITCOIN
$75,610.55
▼ -311.47 (-0.41%)
--:--:--
NYSE · Live ET

Moderna raises its revenue outlook — but all eyes are on what happens next with its cancer vaccine

The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.

Summary from the MarketWatch news feed. Copyright belongs to MarketWatch.

Read full story at MarketWatch ↗

Opens in a new tab, so Investz stays open.

Related on Investz

More headlines

All news
CNBCAnthropic IPO announcement odds drop on Kalshi following midterms and AI sell-offCNBCDynasties or Parity? How MLB, the NFL, and the NBA try to find competitive balanceCNBCWatch live: Jim Cramer shares his next investing moves for this tough marketMarketWatch‘It seems bizarre’: We’re in our 80s with $950,000 in traditional IRAs. Why is our adviser pushing Roth conversions?MarketWatch‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?MarketWatchThese three stars need to align before investors rush back into stocks, Bank of America strategist says

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.

More